Defining, building, and implementing the next wave of biopha...

In a new podcast, pharmaphorum speaks with two PharmaLex experts about navigating complex R&D processes to unleash the next wave of biopharma.

Insights from JP Morgan 2025: Key trends shaping the pharma ...

‘Show me the molecule’ – On synthetic biology and cutting th...

Rare disease and the women's health gap

For women with rare diseases, they often face a double jeopardy, where many of the symptoms they experience can be confused with and misdiagnosed.

Precision medicine, NGS, and the quantum leap in biomarkers

In a new pharmaphorum podcast, web editor Nicole Raleigh speaks with Luca Quagliata, Vice President and Global Head of Medical and Scientific Affairs at Thermo Fisher Scientific, a company

Targeting proteins to bring new medicines to patients with f...

In a new pharmaphorum podcast, editor-in-chief Jonah Comstock speaks with Dr Victoria Richon, CEO of Entact Bio, a company focused on the small molecule space, with its team of scientists,